Table 3.
Proportions of patients below the upper K/DOQIa recommended value (<1.78 mmol/L) for serum phosphate in the ITT populationb
| Mean Serum Phosphate Concentration (mmol/L) | Treatment Arm
|
|||
|---|---|---|---|---|
| Placebo (n = 20) | Fermagate 1 g (n = 21) | Fermagate 2 g (n = 21) | Total (n = 62) | |
| Current therapy | ||||
| ≤1.78 | 13 (65.0) | 14 (66.7) | 15 (71.4) | 42 (67.7) |
| >1.78 | 7 (35.0) | 7 (33.3) | 6 (28.6) | 20 (32.3) |
| Baseline (washout) | ||||
| ≤1.78 | 6 (30.0) | 6 (28.6) | 4 (19.0) | 16 (25.8) |
| >1.78 | 14 (70.0) | 15 (71.4) | 17 (81.0) | 46 (74.2) |
| During treatment | ||||
| ≤1.78 | 6 (30.0) | 11 (52.4) | 17 (81.0) | 34 (54.8) |
| >1.78 | 14 (70.0) | 10 (47.6) | 4 (19.0) | 28 (45.2) |
a
K/DOQI, Kidney Disease Outcomes Quality Initiative.
b
Values are presented as n (%).